{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:30:58Z","timestamp":1792103458303,"version":"4.4.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.ahj.2018.06.010","type":"journal-article","created":{"date-parts":[[2018,6,26]],"date-time":"2018-06-26T21:04:34Z","timestamp":1530047074000},"page":"49-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"special_numbering":"C","title":["Cardiac systolic dysfunction in past illicit users of anabolic androgenic steroids"],"prefix":"10.1016","volume":"203","author":[{"given":"Jon J.","family":"Rasmussen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten","family":"Schou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per L.","family":"Madsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Selmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie L.","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter S.","family":"Ulriksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Dreyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"K\u00fcmler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis L.","family":"Plesner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Faber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Finn","family":"Gustafsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Kistorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2018.06.010_bb0005","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.drugalcdep.2015.04.013","article-title":"Anabolic steroids and cardiovascular risk: A national population-based cohort study","volume":"152","author":"Thiblin","year":"2015","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"10.1016\/j.ahj.2018.06.010_bb0010","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.annepidem.2014.01.009","article-title":"The global epidemiology of anabolic-androgenic steroid use: a meta-analysis and meta-regression analysis","volume":"24","author":"Sagoe","year":"2014","journal-title":"Ann Epidemiol"},{"issue":"3","key":"10.1016\/j.ahj.2018.06.010_bb0015","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.ijcard.2012.03.072","article-title":"Anabolic androgenic steroid use is associated with ventricular dysfunction on cardiac MRI in strength trained athletes","volume":"167","author":"Luijkx","year":"2013","journal-title":"Int J Cardiol"},{"issue":"4","key":"10.1016\/j.ahj.2018.06.010_bb0020","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1161\/CIRCHEARTFAILURE.109.931063","article-title":"Long-term anabolic-androgenic steroid use is associated with left ventricular dysfunction","volume":"3","author":"Baggish","year":"2010","journal-title":"Circ Heart Fail"},{"issue":"4","key":"10.1016\/j.ahj.2018.06.010_bb0025","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1249\/MSS.0b013e3182358cb0","article-title":"Anabolic steroid use and longitudinal, radial, and circumferential cardiac motion","volume":"44","author":"Angell","year":"2012","journal-title":"Med Sci Sports Exerc"},{"issue":"21","key":"10.1016\/j.ahj.2018.06.010_bb0030","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1161\/CIRCULATIONAHA.116.026945","article-title":"Cardiovascular toxicity of illicit anabolic-androgenic Steroid use","volume":"135","author":"Baggish","year":"2017","journal-title":"Circulation"},{"issue":"1\u20133","key":"10.1016\/j.ahj.2018.06.010_bb0035","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1016\/j.forsciint.2011.10.032","article-title":"Anabolic androgenic steroids abuse and cardiac death in athletes: morphological and toxicological findings in four fatal cases","volume":"217","author":"Montisci","year":"2012","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.ahj.2018.06.010_bb0040","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jflm.2015.04.014","article-title":"Pathological changes in anabolic androgenic steroid users","volume":"33","author":"Lusetti","year":"2015","journal-title":"J Forensic Legal Med"},{"key":"10.1016\/j.ahj.2018.06.010_bb0045","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.ijcard.2015.10.186","article-title":"Anabolic-androgenic steroids and athlete's heart: When big is not beautiful","volume":"203","author":"D'Andrea","year":"2016","journal-title":"Int J Cardiol"},{"issue":"4","key":"10.1016\/j.ahj.2018.06.010_bb0050","doi-asserted-by":"crossref","DOI":"10.5812\/asjsm.24058","article-title":"Myocardial scar detected by cardiovascular magnetic resonance in a competitive bodybuilder with longstanding abuse of anabolic steroids","volume":"5","author":"Baumann","year":"2014","journal-title":"Asian J Sports Med"},{"issue":"5","key":"10.1016\/j.ahj.2018.06.010_bb0055","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s00421-014-2820-2","article-title":"Ventricular structure, function, and focal fibrosis in anabolic steroid users: a CMR study","volume":"114","author":"Angell","year":"2014","journal-title":"Eur J Appl Physiol"},{"issue":"4","key":"10.1016\/j.ahj.2018.06.010_bb0060","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jcmg.2011.11.021","article-title":"Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy","volume":"5","author":"Green","year":"2012","journal-title":"JACC Cardiovasc Imaging"},{"issue":"3","key":"10.1016\/j.ahj.2018.06.010_bb0065","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1161\/01.CIR.98.3.256","article-title":"Androgen receptors mediate hypertrophy in cardiac myocytes","volume":"98","author":"Marsh","year":"1998","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.ahj.2018.06.010_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161208","article-title":"Former abusers of anabolic androgenic steroids exhibit decreased testosterone levels and hypogonadal symptoms years after cessation: a case-control study","volume":"11","author":"Rasmussen","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ahj.2018.06.010_bb0075","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/cen.13372","article-title":"Insulin sensitivity in relation to fat distribution and plasma adipocytokines among abusers of anabolic androgenic steroids","volume":"87","author":"Rasmussen","year":"2017","journal-title":"Clin Endocrinol"},{"issue":"2","key":"10.1016\/j.ahj.2018.06.010_bb0080","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/HJH.0000000000001546","article-title":"Increased blood pressure and aortic stiffness among abusers of anabolic androgenic steroids: potential effect of suppressed natriuretic peptides in plasma?","volume":"36","author":"Rasmussen","year":"2018","journal-title":"J Hypertens"},{"issue":"4","key":"10.1016\/j.ahj.2018.06.010_bb0085","first-page":"647","article-title":"Procoagulant state in current and former anabolic androgenic steroid abusers","volume":"118","author":"Chang","year":"2018","journal-title":"Thromb Haemost"},{"issue":"6","key":"10.1016\/j.ahj.2018.06.010_bb0090","doi-asserted-by":"crossref","first-page":"E1172","DOI":"10.1152\/ajpendo.2001.281.6.E1172","article-title":"Testosterone dose-response relationships in healthy young men","volume":"281","author":"Bhasin","year":"2001","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ahj.2018.06.010_bb0095","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1210\/er.2013-1058","article-title":"Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement","volume":"35","author":"Pope","year":"2014","journal-title":"Endocr Rev"},{"issue":"3","key":"10.1016\/j.ahj.2018.06.010_bb0100","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/ehjci\/jev014","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"16","author":"Lang","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"6","key":"10.1016\/j.ahj.2018.06.010_bb0105","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0002-9149(86)90771-X","article-title":"Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings","volume":"57","author":"Devereux","year":"1986","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.ahj.2018.06.010_bb0110","first-page":"303","article-title":"A formula to estimate the approximate surface area if height and weight be known. 1916","volume":"5","author":"Du Bois","year":"1989","journal-title":"Nutrition"},{"issue":"8","key":"10.1016\/j.ahj.2018.06.010_bb0115","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1055\/s-1999-8844","article-title":"Scaling cardiac structural data by body dimensions: a review of theory, practice, and problems","volume":"20","author":"Batterham","year":"1999","journal-title":"Int J Sports Med"},{"issue":"1","key":"10.1016\/j.ahj.2018.06.010_bb0120","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jcmg.2015.11.005","article-title":"T1 Mapping: Basic Techniques and Clinical Applications","volume":"9","author":"Taylor","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"issue":"19","key":"10.1016\/j.ahj.2018.06.010_bb0125","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.jacc.2008.06.049","article-title":"Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping","volume":"52","author":"Iles","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.ahj.2018.06.010_bb0130","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1161\/CIRCIMAGING.113.000633","article-title":"Cardiac magnetic resonance postcontrast T1 time is associated with outcome in patients with heart failure and preserved ejection fraction","volume":"6","author":"Mascherbauer","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"issue":"2","key":"10.1016\/j.ahj.2018.06.010_bb0135","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0378-5122(80)90044-4","article-title":"Interrelationships between sex hormone-binding globulin and testosterone, 5 alpha-dihydrotestosterone and oestradiol-17 beta in blood of normal men","volume":"2","author":"Bartsch","year":"1980","journal-title":"Maturitas"},{"key":"10.1016\/j.ahj.2018.06.010_bb0140","series-title":"Handling Missing Data by Maximum Likelihood","author":"Allison","year":"2012"},{"issue":"15","key":"10.1016\/j.ahj.2018.06.010_bb0145","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1093\/eurheartj\/ehv529","article-title":"Myocardial strain imaging: how useful is it in clinical decision making?","volume":"37","author":"Smiseth","year":"2016","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.ahj.2018.06.010_bb0150","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.116.005521","article-title":"Global longitudinal strain by echocardiography predicts long-term risk of cardiovascular morbidity and mortality in a low-risk general population: the copenhagen city heart study","volume":"10","author":"Biering-Sorensen","year":"2017","journal-title":"Circ Cardiovasc Imaging"},{"issue":"6","key":"10.1016\/j.ahj.2018.06.010_bb0155","doi-asserted-by":"crossref","first-page":"H3575","DOI":"10.1152\/ajpheart.01251.2006","article-title":"Anabolic steroids induce cardiac renin-angiotensin system and impair the beneficial effects of aerobic training in rats","volume":"293","author":"Rocha","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870318301923?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870318301923?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:00:15Z","timestamp":1757570415000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870318301923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":31,"alternative-id":["S0002870318301923"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2018.06.010","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiac systolic dysfunction in past illicit users of anabolic androgenic steroids","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2018.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}